Pharmacological Properties of DOV 315,090, an ocinaplon metabolite

BACKGROUND: Compounds targeting the benzodiazepine binding site of the GABA(A)-R are widely prescribed for the treatment of anxiety disorders, epilepsy, and insomnia as well as for pre-anesthetic sedation and muscle relaxation. It has been hypothesized that these various pharmacological effects are...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Berezhnoy, Dmytro, Gravielle, Maria C, Downing, Scott, Kostakis, Emmanuel, Basile, Anthony S, Skolnick, Phil, Gibbs, Terrell T, Farb, David H
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2008
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2529273/
https://ncbi.nlm.nih.gov/pubmed/18554397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2210-8-11
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak